Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clinical Data
Newton, Massachusetts, United Statesclda.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Before its acquisition, Clinical Data was best known for developing and commercializing vilazodone (marketed as Viibryd), an antidepressant approved by the FDA in 2011 for the treatment of major depressive disorder. The company also developed genetic tests for personalized medicine.
- Therapeutic areas
- OtherPsychiatry
- Modalities
- Small moleculeDiagnostic
- Industry
- Biotech
02
Partnerships
Forest Laboratories (licensing and later acquisition)
Beyond the preview
Go deeper on Clinical Data.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Clinical Data.